IMI EXPANDS SKIN STEROL RESEARCH WITH STUDY EXAMINING NEW CARDIOVASCULAR DISEASE MARKERS

Predictive medicine company IMI International Medical Innovations will initiate a new clinical trial to evaluate the relationship between skin sterol values and a variety of new and established coronary artery disease markers, including ankle/brachial blood pressure index and vascular compliance, in high-risk patients.

Canada NewsWire (http://www.newswire.ca/en/releases/archive/January2005/05/c9947.html)